I am writing with an urgent request for people with vascular dementia that live in easy reach of Nottingham to come forward to take part in research.
The city was chosen as one of 11 locations in the UK to host a clinical trial, led by Alzheimer’s Society and British Heart Foundation, in an effort to find the first ever treatment for this life-altering condition.
We are hoping that an existing blood pressure drug – Amlodipine - could treat vascular dementia but we simply don’t yet have enough participants to carry out the trial in Nottingham.
To find out whether you could be eligible, please call 0115 823 1288 or email email@example.com or visit www.alzheimers.org.uk/vasculartrial
Alzheimer’s Society Services Manager Nottinghamshire